Several reports reference a study discussed by experts claiming that a low-cost weight-loss supplement could significantly improve slimming results. The articles focus on a “75p supplement” and assert that it may boost weight loss by up to 600% compared with baseline outcomes, and that it could outperform GLP-1 injectable medicines such as Mounjaro in terms of reported effectiveness.
The coverage also notes the scale of use of weight-loss injections in the UK, stating that more than 2.5 million people are using “weight-loss jabs,” while some users experience results that are described as less than expected. However, the provided excerpts do not include key study details such as the supplement’s ingredients, study design, participant numbers, duration, comparator groups, safety outcomes, or the specific metrics used to calculate the claimed percentage increase. They also do not present independent replication of the findings.
Overall, the articles describe a provocative claim about drug-free supplementation and compare it with widely used prescription injections, but the available information in these excerpts is limited on evidence specifics.
